Sexual functioning more than 15 years after premenopausal risk-reducing salpingo-oophorectomy
Lara Terra(The Netherlands Cancer Institute), Flora E. van Leeuwen(The Netherlands Cancer Institute), Marian J.E. Mourits(Radboud University Nijmegen), B.F.M. Slangen(Maastricht University Medical Centre), Ellen G. Engelhardt(The Netherlands Cancer Institute), Joanne A. de Hullu(Radboud University Nijmegen), Maarten Beekman(The Netherlands Cancer Institute), E.B.L. van Dorst(Radboud University Nijmegen), Bernadette A. M. Heemskerk‐Gerritsen(Erasmus MC), Jeanine E. Roeters van Lennep(Erasmus MC), Margreet G.E.M. Ausems(McGill University Health Centre), Christi J. van Asperen(Loyola University Medical Center), Marc van Beurden(Oncode Institute), Lieke P. V. Berger(University Medical Center Groningen), Irma van de Beek(Amsterdam University Medical Centers), Constantijne H. Mom, Helena C. van Doorn, Maartje J. Hooning(Erasmus MC Cancer Institute), Klaartje van Engelen(Amsterdam UMC Location University of Amsterdam), Angela H.E.M. Maas(Radboud University Nijmegen), Marijke R. Wevers(Radboud University Nijmegen), Neil K. Aaronson(The Netherlands Cancer Institute), J. Margriet Collée(Erasmus MC Cancer Institute), E. Gómez(Maastricht University Medical Centre), Lizet E. van der Kolk(The Netherlands Cancer Institute), Katja N. Gaarenstroom(Radboud University Nijmegen)
Cited by 8
Related Papers
Cross-Validation of Item Selection and Scoring for the SF-12 Health Survey in Nine Countries
|Journal of Clinical Epidemiology|1998|2.9k
EORTC QLQ-C30 Scoring Manual
|Research at the University of Copenhagen (University of Copenhagen)|1995|2.4k
Translation, Validation, and Norming of the Dutch Language Version of the SF-36 Health Survey in Community and Chronic Disease Populations
|Journal of Clinical Epidemiology|1998|2.3k
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
|New England Journal of Medicine|2018|1.4k
Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma
|Journal of Clinical Oncology|2000|1.3k